Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

This study has been completed.
Sponsor:
Information provided by:
University Hospitals of Cleveland
ClinicalTrials.gov Identifier:
NCT00266084
First received: December 14, 2005
Last updated: NA
Last verified: November 2001
History: No changes posted
  Purpose

This study tested the safety and performance of a new cell collector device and compared the results to those obtained with the current existing device that are being used routinely


Condition Phase
Uterine Cervical Dysplasia
Uterine Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasia
Uterine Cervical Cancer
Phase 1
Phase 2

Study Type: Observational
Official Title: Double-Blinded Multicenter Clinical Study Assessing the Equivalence of the InPath Cervical Cell Collector to the Standard Endocervical Brush and Spatula in Patients Seeking Primary Pap Screening or Follow-Up Screening

Resource links provided by NLM:


Further study details as provided by University Hospitals of Cleveland:

Estimated Enrollment: 85
Study Start Date: August 1999
Estimated Study Completion Date: November 2001
Detailed Description:

This study tested the feasibility, safety and efficacy of the new e2TM Collector, and compared its performance with the standard method for obtaining cervical cells for Pap test of endocervical cytobrush and Ayer’s Spatula

  Eligibility

Ages Eligible for Study:   14 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Women ages >14 being followed for a previous abnormal Pap All patients will have signed an Informed Consent form prior to being enrolled in this study

Exclusion Criteria:

Patients who have had a hysterectomy

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00266084

Sponsors and Collaborators
University Hospitals of Cleveland
Investigators
Principal Investigator: George I Gorodeski, MD PhD University Hospitals of Cleveland, Case Western Reserve University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00266084     History of Changes
Other Study ID Numbers: 02-00-16
Study First Received: December 14, 2005
Last Updated: December 14, 2005
Health Authority: United States: Institutional Review Board

Keywords provided by University Hospitals of Cleveland:
Cervix
Uterus
Dysplasia
Cancer
Collector

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Neoplasms
Carcinoma in Situ
Cervical Intraepithelial Neoplasia
Uterine Cervical Dysplasia
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Precancerous Conditions

ClinicalTrials.gov processed this record on September 16, 2014